Company's Canalevia ®-CA1 (crofelemer delayed-release tablets) prescription drug is FDA conditionally approved for treatment of chemotherapy-induced diarrhea (CID) in dogs and is the first and ...
One Application Covers the Combined Use of Croton lechleri-derived Products and Rifaximin to Address Diarrhea Symptoms The Second is for the Prebiotic Benefit of Crofelemer and Croton lechleri-derived ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback